BioMarin Pharmaceutical, Remote, CA, Remote
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.
Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.
From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases.
The PKU (phenylketonuria) Medical Science Liaison (MSL) is a regional field-based position supporting the scientific and business interests of BioMarin by cultivating current and future thought leaders in academic and clinical medicine at the local, regional and national level through in-depth, fair-balanced scientific engagement and strategic insight gathering.
MSLs are the primary communicators of BioMarin science within a specific geography with healthcare providers and other key stakeholders and are viewed as peer scientific experts in a designated therapeutic area. The MSLs combine their strong business acumen, market awareness, and clinical expertise to serve as a conduit of information to internal cross-functional stakeholders in support of business planning and product development.
In this role, you will identify pre-clinical, clinical and post-marketing study investigators in alignment with PKU Medical Affairs objectives, provide actionable information and insights to internal stakeholders that may enhance the value and appropriate use of BioMarin products. You will also be responsible for supporting the initiation and development of External Research proposals. The MSL must possess in-depth knowledge of BioMarin’s PKU approved products, agents in the pipeline, and all associated disease state areas. The MSL is expected to be a team player and possess the capacity to coordinate and manage initiatives or partnerships with external partners independently or with a minimum amount of oversight. This position will report into the US PKU MSL Director within the Global Medical Affairs (GMAF) department and work closely with GMAF partners as well as the Commercial and the Clinical Teams. Based on therapeutic needs and product life cycles, the MSL team will focus on certain responsibilities to a greater or lesser degree.
_Territory will be focusedin the Western US (includes: WA, OR, CA, AK, HI, MT, ID, NV, UT, AZ, NM). Candidate to be based in the US within the region._
Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
BioMarin is a global biotechnology company focused on developing and commercializing transformative therapies for rare genetic diseases.
View company profile →